Company Filing History:
Years Active: 1989
Title: The Innovations of Kenneth O. Floyd
Introduction
Kenneth O. Floyd is a notable inventor based in the Bronx, NY. He has made significant contributions to the field of cancer research through his innovative work on monoclonal antibodies. His research focuses on developing antibodies that target specific human differentiation antigens associated with various carcinomas.
Latest Patents
Kenneth O. Floyd holds a patent for "Monoclonal antibodies to mucin-like human differentiation antigens." This patent includes three new monoclonal antibodies, MU78, MT334, and MQ49, along with the hybridoma cell lines that produce them. These antibodies are designed to specifically bind to mucin-like antigens, which are crucial in the study and treatment of different types of cancer.
Career Highlights
Floyd is affiliated with the Sloan Kettering Institute for Cancer Research, where he conducts his research. His work has been instrumental in advancing the understanding of cancer biology and developing potential therapeutic strategies.
Collaborations
Throughout his career, Kenneth O. Floyd has collaborated with esteemed colleagues, including M. Jules Mattes and John L. Lewis, Jr. These collaborations have further enriched his research and contributed to the scientific community's knowledge of cancer treatment.
Conclusion
Kenneth O. Floyd's contributions to cancer research through his innovative patents and collaborations highlight his dedication to improving cancer therapies. His work continues to inspire advancements in the field of oncology.